The NBA Won’t Test For Marijuana, Outbreak of Harmful Vapes More Present In Illegal States

A congressman said on Wednesday that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.”

Rep. Earl Blumenauer (D-OR), a longstanding champion of marijuana reform in Congress, made the comments at a symposium on psychedelics policy that was hosted by Harvard Law School’s newly established research institute, the Project on Psychedelics Law and Regulation (POPLAR).

The NBA is extending its policy of not randomly drug testing players for marijuana through the 2021-2022 season, a league spokesperson confirmed on Wednesday.

NBA Commissioner Adam Silver signaled late last year that the temporary suspension of cannabis drug testing may continue. And now Chief Communications Officer Mike Bass is confirming that the policy will be in place at least through the upcoming season that begins this month, according to The Associated Press.

WASHINGTON, Oct. 6, 2021 – U.S. Department of Agriculture (USDA) Secretary Tom Vilsack announced today an investment of more than 6 million in sustainable agricultural research projects aimed at improving a robust, resilient, climate-smart food and agricultural system.

This investment is made under the National Institute of Food and Agriculture’s (NIFA) Sustainable Agricultural Systems program. This innovative program focuses on a broad base of needed research solutions from addressing labor challenges and promoting land stewardship to correcting climate change impacts in agriculture and critical needs in food and nutrition.

New federally funded research has identified another public health protection that is associated with states enacting laws to legalize marijuana.

Just before the COVID-19 pandemic, an outbreak of a different mysterious respiratory disease emerged among some users of cannabis concentrates and e-cigarettes. Eventually linked to an additive found most commonly in unregulated marijuana vape cartridges, the illness sickened nearly 3,000 people in the U.S. and killed 68, according to the Centers for Disease Control and Prevention (CDC).

A recent study of the outbreak, published late last month in the journal Drug and Alcohol Dependence, analyzed the relationship between state cannabis policies and the prevalence of the illness, known as EVALI (e-cigarette and vaping-associated lung injury). It found that in states where cannabis was legal for adults, or where medical marijuana patients could legally grow their own cannabis, EVALI was significantly less prevalent.

Pennsylvania is becoming something of a hotbed for marijuana legalization legislation, with a Democratic state lawmaker on Tuesday announcing his intent to file a reform bill that he’ll be working on with a Republican senator who announced his support for the policy change a day earlier.

There are also two other Pennsylvania legalization proposals that have been separately announced—one of which was formally introduced late last month and the other still being drafted.

New York Gov. Kathy Hochul has picked up the slack left by her predecessor after New York officially legalized marijuana back in March, but still isn’t able to provide a date for when New Yorkers will be able to purchase it legally.

Insider tried to question Hochul about it during a brief press conference she held on Wednesday, and asked the governor’s office after she ended the gaggle at the Museum of Jewish Heritage in Manhattan’s Battery Park.

Montana regulators adopted rules on marijuana cultivation canopy tier size increases and limitations on advertising.

Stonington, Connecticut voters rejected a proposed ban on marijuana businesses.

A study suggested that “CBGA, CBDVA, and CBGVA may contribute to the effects of cannabis-based products in childhood epilepsy.”

Leave a Reply